{"id":75295,"date":"2026-09-25T05:30:30","date_gmt":"2026-09-25T05:30:30","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=75295"},"modified":"2026-09-25T05:30:30","modified_gmt":"2026-09-25T05:30:30","slug":"analyst-updates-sept-24-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/","title":{"rendered":"Analyst Updates: Sept 24, 2026"},"content":{"rendered":"

Analyst Ratings:<\/strong><\/h2>\n
The latest 340 Canadian and US analyst updates suggest a selective market outlook. Target cuts across asset management, gold mining, real estate, banking, restaurants and consumer businesses point to more cautious earnings and valuation expectations, even where positive ratings remain. At the same time, higher targets in technology, software, transportation and selected smaller companies show that analysts still see opportunities for growth. Overall, the ratings favour stock selection over a broad market rally, with investors likely to focus on companies that can support their valuations through stronger results.<\/div>\n

Canadian Analyst Ratings<\/strong><\/h3>\n

AGF Management Ltd. (AGF.B:CA) \u2014 TD Securities lowered its price target to $20.00 from $23.00 and maintained a Buy rating.<\/p>\n

AGF Management Ltd. (AGF.B:CA) \u2014 BMO lowered its price target to $19.00 from $21.00; no rating was provided.<\/p>\n

AGF Management Ltd. (AGF.B:CA) \u2014 Desjardins Securities lowered its price target to $21.00 from $23.00 and maintained a Buy rating.<\/p>\n

AGF Management Ltd. (AGF.B:CA) \u2014 RBC Capital lowered its price target to $20.00 from $23.00 and maintained a Sector Perform rating.<\/p>\n

BlackBerry Limited (BB:CA) \u2014 CIBC lowered its price target to $18.00 and maintained an Outperform rating; the previous target was not provided.<\/p>\n

Cameco Corp. (CCO:CA) \u2014 RBC Capital maintained an Outperform rating and a $184.00 price target.<\/p>\n

Cameco Corp. (CCO:CA) \u2014 TD Securities maintained a Buy rating and a $190.00 price target.<\/p>\n

Canadian National Railway Co. (CNR:CA) \u2014 RBC Capital lowered its price target to $198.00 from $205.00 and maintained an Outperform rating.<\/p>\n

Canadian National Railway Co. (CNR:CA) \u2014 CIBC maintained an Outperform rating and a $198.00 price target.<\/p>\n

Canadian Pacific Kansas City Ltd. (CP:CA) \u2014 RBC Capital raised its price target to $146.00 from $145.00 and maintained an Outperform rating.<\/p>\n

Dexterra Group Inc. (DXT:CA) \u2014 Raymond James raised its price target to $20.00 from $18.50 and maintained an Outperform rating.<\/p>\n

Gildan Activewear Inc. (GIL:CA) \u2014 TD Securities lowered its price target to $76.00 from $113.00 and maintained a Buy rating.<\/p>\n

Ivanhoe Electric Inc. (IE:CA) \u2014 Raymond James lowered its price target to $20.00 from $21.00 and maintained an Outperform rating.<\/p>\n

Kinross Gold Corp. (K:CA) \u2014 Desjardins Securities lowered its price target to $53.00 from $58.00 and maintained a Buy rating.<\/p>\n

Kinross Gold Corp. (K:CA) \u2014 Scotiabank lowered its price target to $55.00 from $58.00 and maintained a Sector Outperform rating.<\/p>\n

Kinross Gold Corp. (K:CA) \u2014 Canaccord Genuity lowered its price target to $66.50 from $73.50 and maintained a Buy rating.<\/p>\n

Kinross Gold Corp. (K:CA) \u2014 BMO lowered its price target to $48.00 from $49.00 and maintained an Outperform rating.<\/p>\n

Kinross Gold Corp. (K:CA) \u2014 TD Securities lowered its price target to $49.50 from $56.50 and maintained a Buy rating.<\/p>\n

Orezone Gold Corp. (ORE:CA) \u2014 National Bank raised its price target to $4.25 from $4.00 and maintained an Outperform rating.<\/p>\n

Slate Grocery REIT (SGR.U:CA) \u2014 ATB Cormark lowered its price target to $8.00 from $13.00 and maintained an Underperform rating.<\/p>\n

Slate Grocery REIT (SGR.U:CA) \u2014 CIBC lowered its price target to $8.25 from $12.00 and maintained a Neutral rating.<\/p>\n

Stingray Group Inc. (RAY:CA) \u2014 CIBC maintained an Outperform rating and a $19.00 price target.<\/p>\n

Thinkific Labs Inc. (THNC:CA) \u2014 ATB Cormark raised its price target to $3.25 from $2.25 and maintained an Outperform rating.<\/p>\n

Total Energy Services Inc. (TOT:CA) \u2014 RBC Capital initiated coverage with a Sector Perform rating and a $41.00 price target.<\/p>\n

Total Energy Services Inc. (TOT:CA) \u2014 ATB Cormark raised its price target to $42.00 from $36.50 and maintained an Outperform rating.<\/p>\n

US Analyst Ratings<\/strong><\/h3>\n

3M (MMM) \u2014 Wells Fargo & Company set a price target of $195.00 for the stock.<\/p>\n

Aardvark Therapeutics (AARD) \u2014 Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $6.00.<\/p>\n

AbCellera Biologics (ABCL) \u2014 Goldman initiated coverage of the company with a Neutral rating and a price target of $13.<\/p>\n

AC Immune (ACIU) \u2014 HC Wainwright reiterated its Buy rating on the stock.<\/p>\n

ACADIA Pharmaceuticals (ACAD) \u2014 BMO Capital Markets reiterated its Outperform rating on the stock.<\/p>\n

ACADIA Pharmaceuticals (ACAD) \u2014 Citigroup lowered its price target for the stock to $33.00 from $40.00 while maintaining a Buy rating.<\/p>\n

ACADIA Pharmaceuticals (ACAD) \u2014 Needham & Company LLC reiterated its Buy rating on the stock with a price target of $41.00.<\/p>\n

ACADIA Pharmaceuticals (ACAD) \u2014 TD Cowen reiterated its Buy rating on the stock.<\/p>\n

Afya (AFYA) \u2014 Bradesco Corretora upgraded the stock to Outperform and set a price target of $17.00.<\/p>\n

Alexandria RE (ARE) \u2014 JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $56.<\/p>\n

Alexandria Real Estate Equities (ARE) \u2014 Jefferies Financial Group lowered its price target for the stock to $46.00 from $47.00 while maintaining a Hold rating.<\/p>\n

Alight (ALIT) \u2014 DA Davidson lowered its price target for the stock to $22.00 from $32.00 while maintaining a Buy rating.<\/p>\n

Alkami Technology (ALKT) \u2014 Citigroup reiterated its Market Outperform rating on the stock.<\/p>\n

Alkami Technology (ALKT) \u2014 Citizens Jmp reiterated its Market Outperform rating on the stock with a price target of $24.00.<\/p>\n

Alkami Technology (ALKT) \u2014 JP Morgan downgraded the stock from Overweight to Underweight and lowered its price target to $14.00 from $24.00.<\/p>\n

Alkermes (ALKS) \u2014 The Goldman Sachs Group reiterated its Neutral rating on the stock with a price target of $50.00.<\/p>\n

Almonty Industries (ALM) \u2014 The Goldman Sachs Group initiated coverage of the company with a Neutral rating and a price target of $13.00.<\/p>\n

Americold Realty Trust (COLD) \u2014 JP Morgan upgraded the stock from Underweight to Neutral and set a price target of $16.<\/p>\n

Angi (ANGI) \u2014 UBS Group set a price target of $14.00 for the stock.<\/p>\n

Anheuser-Busch InBev SA\/NV (BUD) \u2014 Bank of America reiterated its Buy rating on the stock.<\/p>\n

Anheuser-Busch InBev SA\/NV (BUD) \u2014 Deutsche Bank Aktiengesellschaft reiterated its Buy rating on the stock.<\/p>\n

Anheuser-Busch InBev SA\/NV (BUD) \u2014 Jefferies Financial Group reiterated its Buy rating on the stock.<\/p>\n

Anheuser-Busch InBev SA\/NV (BUD) \u2014 JPMorgan Chase & Co. reiterated its Buy rating on the stock.<\/p>\n

Anheuser-Busch InBev SA\/NV (BUD) \u2014 UBS Group reiterated its Buy rating on the stock.<\/p>\n

Arcturus Therapeutics (ARCT) \u2014 BTIG Research lowered its price target for the stock to $20.00 from $23.00 while maintaining a Buy rating.<\/p>\n

Arcturus Therapeutics (ARCT) \u2014 Cantor Fitzgerald reiterated its Overweight rating on the stock.<\/p>\n

Arcturus Therapeutics (ARCT) \u2014 Citigroup upgraded the stock from Neutral to Buy and raised its price target to $20.00 from $8.00.<\/p>\n

Ares Management (ARES) \u2014 Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $150.<\/p>\n

Arrowhead (ARWR) \u2014 Goldman resumed coverage of the company with a Neutral rating and a price target of $74.<\/p>\n

Arthur J. Gallagher & Co. (AJG) \u2014 Cantor Fitzgerald reiterated its Neutral rating on the stock.<\/p>\n

Arthur J. Gallagher & Co. (AJG) \u2014 Keefe, Bruyette & Woods reiterated its Market Perform rating on the stock.<\/p>\n

Arthur J. Gallagher & Co. (AJG) \u2014 Piper Sandler reiterated its Overweight rating on the stock.<\/p>\n

Arthur J. Gallagher & Co. (AJG) \u2014 Royal Bank Of Canada lowered its price target for the stock to $290.00 from $310.00 while maintaining a Outperform rating.<\/p>\n

Arthur J. Gallagher & Co. (AJG) \u2014 Wells Fargo & Company lowered its price target for the stock to $291.00 from $296.00 while maintaining a Overweight rating.<\/p>\n

Aurora Innovation (AUR) \u2014 Canaccord Genuity Group raised its price target for the stock to $17.00 from $15.00 while maintaining a Buy rating.<\/p>\n

Aurora Innovation (AUR) \u2014 Needham & Company LLC reiterated its Buy rating on the stock with a price target of $13.00.<\/p>\n

Aurora Innovation (AUR) \u2014 The Goldman Sachs Group raised its price target for the stock to $7.00 from $6.00 while maintaining a Neutral rating.<\/p>\n

Autodesk (ADSK) \u2014 UBS Group reiterated its Buy rating on the stock.<\/p>\n

Bank of America (BAC) \u2014 Jefferies Financial Group lowered its price target for the stock to $70.00 from $75.00 while maintaining a Buy rating.<\/p>\n

Beta Bionics (BBNX) \u2014 Truist Financial raised its price target for the stock to $28.00 from $23.00 while maintaining a Buy rating.<\/p>\n

Blue Owl Capital (OWL) \u2014 Citigroup reiterated its Market Outperform rating on the stock.<\/p>\n

Blue Owl Capital (OWL) \u2014 HSBC set a price target of $17.00 for the stock.<\/p>\n

BlueLinx (BXC) \u2014 Citigroup initiated coverage of the company with a Market Perform rating.<\/p>\n

BlueLinx (BXC) \u2014 Citizens initiated coverage of the company with a Market Perform rating.<\/p>\n

BMW Group (BMWKY) \u2014 HSBC Securities downgraded the stock from Buy to Hold.<\/p>\n

Booking (BKNG) \u2014 BTIG Research reiterated its Buy rating on the stock with a price target of $250.00.<\/p>\n

Booking (BKNG) \u2014 Citigroup reiterated its Market Perform rating on the stock.<\/p>\n

Brixmor Property Group (BRX) \u2014 Mizuho lowered its price target for the stock to $30.00 from $33.00 while maintaining a Outperform rating.<\/p>\n

BWX Technologies (BWXT) \u2014 BNP Paribas Exane lowered its price target for the stock to $165.00 from $190.00 while maintaining a Neutral rating.<\/p>\n

Cal-Maine Foods (CALM) \u2014 BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $75.00 from $83.00.<\/p>\n

Canadian Pacific Kansas City (CP) \u2014 Royal Bank Of Canada reiterated its Outperform rating on the stock.<\/p>\n

CareDx (CDNA) \u2014 BTIG Research raised its price target for the stock to $74.00 from $60.00 while maintaining a Buy rating.<\/p>\n

Carlyle Group (CG) \u2014 Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $54.<\/p>\n

Carnival (CCL) \u2014 JPMorgan Chase & Co. lowered its price target for the stock to $39.00 from $43.00 while maintaining a Overweight rating.<\/p>\n

Carnival (CCL) \u2014 Susquehanna lowered its price target for the stock to $28.00 from $33.00 while maintaining a Positive rating.<\/p>\n

Carrier Global (CARR) \u2014 Wells Fargo & Company set a price target of $67.00 for the stock and changed its rating from Negative to Overweight.<\/p>\n

Cinemark (CNK) \u2014 Morgan Stanley lowered its price target for the stock to $40.00 from $42.00 while maintaining a Equal Weight rating.<\/p>\n

Cintas (CTAS) \u2014 Robert W. Baird changed its price target for the stock to $222.00 from $214.00 with an Outperform rating.<\/p>\n

Cintas (CTAS) \u2014 Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $206.00.<\/p>\n

Cintas (CTAS) \u2014 Truist Financial raised its price target for the stock to $230.00 from $225.00 while maintaining a Buy rating.<\/p>\n

Cintas (CTAS) \u2014 UBS Group reiterated its Buy rating on the stock and raised its price target to $235.00 from $230.00.<\/p>\n

CNB Financial (CCNE) \u2014 Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $38.<\/p>\n

Colliers International Group (CIGI) \u2014 BMO Capital Markets reiterated its Outperform rating on the stock.<\/p>\n

Comcast (CMCSA) \u2014 Citigroup lowered its price target for the stock to $27.50 from $30.00 while maintaining a Buy rating.<\/p>\n

Comcast (CMCSA) \u2014 KeyCorp downgraded the stock from Sector Weight to Underweight and set a price target of $18.00.<\/p>\n

CoreWeave (CRWV) \u2014 JP Morgan upgraded the stock from Neutral to Overweight and raised its price target to $125.00 from $120.00.<\/p>\n

Corteva (CTVA) \u2014 Oppenheimer reiterated its Outperform rating on the stock with a price target of $95.00.<\/p>\n

Cracker Barrel Old Country Store (CBRL) \u2014 Bank of America reiterated its Underperform rating on the stock with a price target of $48.00.<\/p>\n

CSX (CSX) \u2014 Royal Bank Of Canada lowered its price target for the stock to $53.00 from $54.00 while maintaining a Outperform rating.<\/p>\n

Cummins (CMI) \u2014 Bank of America lowered its price target for the stock to $600.00 from $731.00.<\/p>\n

Darden Restaurants (DRI) \u2014 TD Cowen reiterated its Hold rating on the stock with a price target of $215.00.<\/p>\n

Deere & Company (DE) \u2014 Bank of America raised its price target for the stock to $715.00 from $667.00.<\/p>\n

Delta Air Lines (DAL) \u2014 UBS Group raised its price target for the stock to $105.00 from $99.00 while maintaining a Buy rating.<\/p>\n

Dollar General (DG) \u2014 HSBC Securities upgraded the stock from Hold to Buy and raised its price target to $160.00 from $125.00.<\/p>\n

Dover (DOV) \u2014 Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $229.00.<\/p>\n

DraftKings (DKNG) \u2014 Citizens reiterated its Market Outperform rating on the stock and lowered its price target to $35 from $37.<\/p>\n

Dropbox (DBX) \u2014 Citigroup downgraded the stock from Neutral to Sell and lowered its price target to $29.00 from $33.00.<\/p>\n

Dycom Industries (DY) \u2014 Cantor Fitzgerald reiterated its Overweight rating on the stock with a price target of $476.00.<\/p>\n

Dynatrace (DT) \u2014 Oppenheimer reiterated its Outperform rating on the stock and raised its price target to $71 from $60.<\/p>\n

EastGroup (EGP) \u2014 JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $231.<\/p>\n

Eaton (ETN) \u2014 Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $503.00.<\/p>\n

eBay (EBAY) \u2014 Arete Research lowered its price target for the stock to $111.00 from $113.00 while maintaining a Neutral rating.<\/p>\n

Edison International (EIX) \u2014 UBS Group reiterated its Neutral rating on the stock with a price target of $57.00.<\/p>\n

Elicio Therapeutics (ELTX) \u2014 B. Riley Financial set a price target of $8.00 for the stock while maintaining a Buy rating.<\/p>\n

Energy Services of America (ESOA) \u2014 Roth Capital initiated coverage of the company with a Buy rating and a price target of $20.<\/p>\n

Entera Bio (ENTX) \u2014 Guggenheim initiated coverage of the company with a Buy rating.<\/p>\n

Essential Properties Realty Trust (EPRT) \u2014 Scotiabank lowered its price target for the stock to $30.00 from $33.00 while maintaining a Sector Outperform rating.<\/p>\n

Ethos Technologies Inc. Class A Common Stock (LIFE) \u2014 Bank of America reiterated its Buy rating on the stock with a price target of $38.00.<\/p>\n

Etsy (ETSY) \u2014 Arete downgraded the stock from Buy to Neutral and set a price target of $81.<\/p>\n

Etsy (ETSY) \u2014 Arete Research set a price target of $81.00 for the stock and changed its rating from Buy to Neutral.<\/p>\n

Eupraxia Pharmaceuticals (EPRX) \u2014 Stifel Nicolaus set a price target of $25.00 for the stock.<\/p>\n

Eupraxia Pharmaceuticals (EPRX) \u2014 Wedbush initiated coverage of the company with an Outperform rating and a price target of $17.<\/p>\n

Everpure (P) \u2014 Citigroup raised its price target for the stock to $160.00 from $130.00 while maintaining a Buy rating.<\/p>\n

Everpure (P) \u2014 Evercore reiterated its Outperform rating on the stock with a price target of $145.00.<\/p>\n

Everpure (P) \u2014 Guggenheim reiterated its Buy rating on the stock with a price target of $150.00.<\/p>\n

Everpure (P) \u2014 Lake Street Capital raised its price target for the stock to $130.00 from $120.00 while maintaining a Buy rating.<\/p>\n

Everpure (P) \u2014 Morgan Stanley raised its price target for the stock to $137.00 from $119.00 while maintaining a Overweight rating.<\/p>\n

Everpure (P) \u2014 Needham & Company LLC raised its price target for the stock to $150.00 from $140.00 while maintaining a Buy rating.<\/p>\n

Everpure (P) \u2014 Northland Securities set a price target of $167.00 for the stock.<\/p>\n

Everpure (P) \u2014 Piper Sandler raised its price target for the stock to $162.00 from $133.00 while maintaining a Overweight rating.<\/p>\n

Everpure (P) \u2014 Wedbush reiterated its Outperform rating on the stock with a price target of $130.00.<\/p>\n

Everpure (P) \u2014 Wells Fargo & Company raised its price target for the stock to $145.00 from $135.00 while maintaining a Overweight rating.<\/p>\n

Federal Realty Investment Trust (FRT) \u2014 Mizuho lowered its price target for the stock to $117.00 from $130.00 while maintaining a Outperform rating.<\/p>\n

Federal Realty Investment Trust (FRT) \u2014 UBS Group set a price target of $117.00 for the stock.<\/p>\n

Fervo Energy (FRVO) \u2014 Johnson Rice initiated coverage of the company with a Buy rating and a price target of $35.<\/p>\n

Fervo Energy (FRVO) \u2014 Sanford C. Bernstein reiterated its Outperform rating on the stock with a price target of $47.00.<\/p>\n

Fifth Third Bancorp (FITB) \u2014 Jefferies Financial Group lowered its price target for the stock to $65.00 from $70.00 while maintaining a Buy rating.<\/p>\n

First Financial Bancorp. (FFBC) \u2014 Truist Financial set a price target of $37.00 for the stock and changed its rating from Hold to Buy.<\/p>\n

Forgent Power Solutions (FPS) \u2014 Wells Fargo & Company set a price target of $44.00 for the stock.<\/p>\n

Frontier Group (ULCC) \u2014 UBS Group lowered its price target for the stock to $6.00 from $7.00 while maintaining a Neutral rating.<\/p>\n

FuelCell Energy (FCEL) \u2014 Barclays initiated coverage of the company with an Equal Weight rating and a price target of $20.<\/p>\n

Gaming and Leisure Properties (GLPI) \u2014 JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $46.<\/p>\n

Gaming and Leisure Properties (GLPI) \u2014 Scotiabank lowered its price target for the stock to $43.00 from $49.00 while maintaining a Sector Perform rating.<\/p>\n

General Mills (GIS) \u2014 Bank of America reiterated its Neutral rating on the stock.<\/p>\n

General Mills (GIS) \u2014 Deutsche Bank reiterated its Hold rating on the stock and raised its price target to $34 from $33.<\/p>\n

General Mills (GIS) \u2014 Deutsche Bank Aktiengesellschaft reiterated its Hold rating on the stock and raised its price target to $34.00 from $33.00.<\/p>\n

General Mills (GIS) \u2014 Piper Sandler reiterated its Overweight rating on the stock.<\/p>\n

General Mills (GIS) \u2014 Sanford C. Bernstein reiterated its Underperform rating on the stock with a price target of $30.00.<\/p>\n

General Mills (GIS) \u2014 TD Cowen reiterated its Hold rating on the stock and raised its price target to $33 from $32.<\/p>\n

General Motors (GM) \u2014 TD Cowen reiterated its Hold rating on the stock.<\/p>\n

General Motors (GM) \u2014 UBS Group set a price target of $33.00 for the stock.<\/p>\n

Getty Realty (GTY) \u2014 KeyCorp reiterated its Overweight rating on the stock with a price target of $36.00.<\/p>\n

Gildan Activewear (GIL) \u2014 TD lowered its price target for the stock to $54.00 from $80.00 while maintaining a Buy rating.<\/p>\n

Gildan Activewear (GIL) \u2014 TD Securities lowered its price target for the stock to $54.00 from $80.00 while maintaining a Buy rating.<\/p>\n

Global Payments (GPN) \u2014 Loop Capital initiated coverage of the company with a Buy rating and a price target of $137.00.<\/p>\n

Golar LNG (GLNG) \u2014 BTIG Research raised its price target for the stock to $75.00 from $70.00 while maintaining a Buy rating.<\/p>\n

GRAIL (GRAL) \u2014 TD Cowen reiterated its Buy rating on the stock.<\/p>\n

Harmony Biosciences (HRMY) \u2014 Oppenheimer reiterated its Outperform rating on the stock.<\/p>\n

Hubbell (HUBB) \u2014 Wells Fargo & Company set a price target of $531.00 for the stock.<\/p>\n

Huntington Bancshares (HBAN) \u2014 Jefferies Financial Group lowered its price target for the stock to $17.00 from $18.00 while maintaining a Hold rating.<\/p>\n

IMAX (IMAX) \u2014 Morgan Stanley initiated coverage of the company with an Overweight rating and a price target of $63.<\/p>\n

Immunovant (IMVT) \u2014 Citigroup reiterated its Positive rating on the stock.<\/p>\n

Immunovant (IMVT) \u2014 HC Wainwright reiterated its Buy rating on the stock.<\/p>\n

Insmed (INSM) \u2014 Goldman resumed coverage of the company with a Buy rating and a price target of $188.<\/p>\n

Intel (INTC) \u2014 TD Cowen reiterated its Hold rating on the stock with a price target of $115.00.<\/p>\n

International Paper (IP) \u2014 Argus reiterated its Buy rating on the stock with a price target of $45.00.<\/p>\n

Intuit (INTU) \u2014 The Goldman Sachs Group reiterated its Sell rating on the stock.<\/p>\n

Ionis Pharmaceuticals (IONS) \u2014 HC Wainwright reiterated its Buy rating on the stock with a price target of $100.00.<\/p>\n

Ionis Pharmaceuticals (IONS) \u2014 Oppenheimer reiterated its Outperform rating on the stock with a price target of $85.00.<\/p>\n

Iovance Biotherapeutics (IOVA) \u2014 Goldman resumed coverage of the company with a Buy rating and a price target of $15.<\/p>\n

Jazz Pharma (JAZZ) \u2014 Goldman resumed coverage of the company with a Buy rating and a price target of $337.<\/p>\n

JBT Marel (JBTM) \u2014 Robert W. Baird lowered its price target for the stock to $171.00 from $188.00 while maintaining a Outperform rating.<\/p>\n

Johnson Controls International (JCI) \u2014 Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $186.00.<\/p>\n

JPMorgan Chase & Co. (JPM) \u2014 Jefferies Financial Group lowered its price target for the stock to $365.00 from $370.00 while maintaining a Hold rating.<\/p>\n

KeyCorp (KEY) \u2014 Jefferies Financial Group lowered its price target for the stock to $22.00 from $24.00 while maintaining a Hold rating.<\/p>\n

Kimco Realty (KIM) \u2014 Mizuho lowered its price target for the stock to $23.00 from $25.00 while maintaining a Neutral rating.<\/p>\n

Kimco Realty (KIM) \u2014 UBS Group set a price target of $23.00 for the stock.<\/p>\n

Kinross Gold (KGC) \u2014 Canaccord Genuity Group lowered its price target for the stock to $47.00 from $52.00 while maintaining a Buy rating.<\/p>\n

Kinross Gold (KGC) \u2014 Scotia lowered its price target for the stock to $39.00 from $41.00 while maintaining a Sector Outperform rating.<\/p>\n

Kinross Gold (KGC) \u2014 Scotiabank lowered its price target for the stock to $39.00 from $41.00 while maintaining a Sector Outperform rating.<\/p>\n

Kinross Gold (KGC) \u2014 TD lowered its price target for the stock to $35.00 from $40.00 while maintaining a Buy rating.<\/p>\n

Kinross Gold (KGC) \u2014 TD Securities lowered its price target for the stock to $35.00 from $40.00 while maintaining a Buy rating.<\/p>\n

Kite Realty (KRG) \u2014 JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $27.<\/p>\n

Knife River (KNF) \u2014 Oppenheimer lowered its price target for the stock to $80.00 from $90.00 while maintaining a Outperform rating.<\/p>\n

Kodiak Sciences (KOD) \u2014 Goldman resumed coverage of the company with a Neutral rating and a price target of $36.<\/p>\n

Kraft Heinz (KHC) \u2014 Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $32.00.<\/p>\n

Krystal Biotech (KRYS) \u2014 Goldman resumed coverage of the company with a Buy rating and a price target of $441.<\/p>\n

Ligand Pharmaceuticals (LGND) \u2014 HC Wainwright reiterated its Buy rating on the stock with a price target of $358.00.<\/p>\n

Lindsay (LNN) \u2014 Stifel Nicolaus set a price target of $121.00 for the stock.<\/p>\n

Lowe’s (LOW) \u2014 Gordon Haskett downgraded the stock from Buy to Hold and set a price target of $200.<\/p>\n

Lumexa Imaging (LMRI) \u2014 KeyCorp initiated coverage of the company with an Overweight rating and a price target of $18.00.<\/p>\n

LuxExperience B.V. (LUXE) \u2014 TD Cowen raised its price target for the stock to $11.00 from $9.00 while maintaining a Buy rating.<\/p>\n

M&T Bank (MTB) \u2014 Jefferies Financial Group lowered its price target for the stock to $275.00 from $300.00 while maintaining a Buy rating.<\/p>\n

Macerich (MAC) \u2014 JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $26.<\/p>\n

Madrigal Pharmaceuticals (MDGL) \u2014 Goldman resumed coverage of the company with a Buy rating and a price target of $704.<\/p>\n

Maze Therapeutics (MAZE) \u2014 HC Wainwright reiterated its Buy rating on the stock with a price target of $110.00.<\/p>\n

McDonald’s (MCD) \u2014 BMO Capital Markets reiterated its Outperform rating on the stock and lowered its price target to $310 from $335.<\/p>\n

McDonald’s (MCD) \u2014 BTIG Research reiterated its Buy rating on the stock and lowered its price target to $295 from $350.<\/p>\n

McDonald’s (MCD) \u2014 Evercore ISI reiterated its Outperform rating on the stock and lowered its price target to $300 from $320.<\/p>\n

McDonald’s (MCD) \u2014 Jefferies Financial Group reiterated its Buy rating on the stock with a price target of $325.00.<\/p>\n

McDonald’s (MCD) \u2014 JP Morgan reiterated its Overweight rating on the stock and lowered its price target to $260 from $280.<\/p>\n

McDonald’s (MCD) \u2014 Oppenheimer reiterated its Outperform rating on the stock and lowered its price target to $295 from $325.<\/p>\n

McDonald’s (MCD) \u2014 RBC Capital Mkts reiterated its Sector Perform rating on the stock and lowered its price target to $285 from $290.<\/p>\n

McDonald’s (MCD) \u2014 Robert W. Baird reiterated its Neutral rating on the stock and lowered its price target to $250 from $285.<\/p>\n

McDonald’s (MCD) \u2014 TD Cowen lowered its price target for the stock to $270.00 from $282.00 while maintaining a Hold rating.<\/p>\n

McDonald’s (MCD) \u2014 UBS Group set a price target of $260.00 for the stock.<\/p>\n

MediWound (MDWD) \u2014 TD Cowen reiterated its Buy rating on the stock.<\/p>\n

MeiraGTx (MGTX) \u2014 Goldman initiated coverage of the company with a Neutral rating and a price target of $16.<\/p>\n

Mesoblast (MESO) \u2014 Cantor Fitzgerald reiterated its Overweight rating on the stock.<\/p>\n

Meta Platforms (META) \u2014 Citigroup reiterated its Outperform rating on the stock.<\/p>\n

Meta Platforms (META) \u2014 Citizens Jmp raised its price target for the stock to $885.00 from $770.00 while maintaining a Market Outperform rating.<\/p>\n

Meta Platforms (META) \u2014 JPMorgan Chase & Co. raised its price target for the stock to $920.00 from $820.00 while maintaining a Overweight rating.<\/p>\n

Meta Platforms (META) \u2014 Loop Capital raised its price target for the stock to $955.00 from $740.00 while maintaining a Buy rating.<\/p>\n

Meta Platforms (META) \u2014 Raymond James Financial raised its price target for the stock to $860.00 from $650.00 while maintaining a Strong-Buy rating.<\/p>\n

Meta Platforms (META) \u2014 Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $770.00.<\/p>\n

Meta Platforms (META) \u2014 President Capital upgraded the stock from Neutral to Buy and raised its price target to $897.00 from $660.00.<\/p>\n

Meta Platforms (META) \u2014 Tigress Financial raised its price target for the stock to $995.00 from $945.00 while maintaining a Strong-Buy rating.<\/p>\n

MGE Energy (MGEE) \u2014 BofA Securities initiated coverage of the company with a Neutral rating and a price target of $76.<\/p>\n

MGM Resorts International (MGM) \u2014 Mizuho lowered its price target for the stock to $55.00 from $60.00 while maintaining a Outperform rating.<\/p>\n

MGM Resorts International (MGM) \u2014 Susquehanna lowered its price target for the stock to $46.00 from $55.00 while maintaining a Positive rating.<\/p>\n

MGM Resorts (MGM) \u2014 BofA Securities resumed coverage of the company with a Neutral rating and a price target of $40.<\/p>\n

Micron Technology (MU) \u2014 Rosenblatt Securities reiterated its Buy rating on the stock with a price target of $1,500.00.<\/p>\n

MiniMed Group (MMED) \u2014 Truist Financial initiated coverage of the company with a Buy rating and a price target of $29.00.<\/p>\n

MiniMed (MMED) \u2014 Truist initiated coverage of the company with a Buy rating and a price target of $29.<\/p>\n

MongoDB (MDB) \u2014 Evercore reiterated its Outperform rating on the stock.<\/p>\n

Nebius Group N.V. (NBIS) \u2014 BNP Paribas Exane upgraded the stock from Neutral to Outperform and raised its price target to $399.00 from $260.00.<\/p>\n

NeOnc Technologies Holdings (NTHI) \u2014 Roth Capital initiated coverage of the company with a Buy rating and a price target of $20.<\/p>\n

NeoVolta (NEOV) \u2014 Needham & Company LLC reiterated its Buy rating on the stock with a price target of $8.00.<\/p>\n

NETSTREIT (NTST) \u2014 Scotiabank lowered its price target for the stock to $20.00 from $22.00 while maintaining a Sector Outperform rating.<\/p>\n

Newmark Group (NMRK) \u2014 Keefe, Bruyette & Woods reiterated its Outperform rating on the stock.<\/p>\n

NiCE (NICE) \u2014 Royal Bank Of Canada raised its price target for the stock to $145.00 from $130.00 while maintaining a Outperform rating.<\/p>\n

Norfolk Southern (NSC) \u2014 Royal Bank Of Canada lowered its price target for the stock to $330.00 from $360.00 while maintaining a Sector Perform rating.<\/p>\n

Norwegian Cruise Line (NCLH) \u2014 JPMorgan Chase & Co. lowered its price target for the stock to $13.00 from $17.00 while maintaining a Neutral rating.<\/p>\n

Norwegian Cruise Line (NCLH) \u2014 Truist Financial lowered its price target for the stock to $16.00 from $20.00 while maintaining a Hold rating.<\/p>\n

Nuvectis Pharma (NVCT) \u2014 HC Wainwright reiterated its Buy rating on the stock with a price target of $39.00.<\/p>\n

nVent Electric (NVT) \u2014 Wells Fargo & Company set a price target of $182.00 for the stock.<\/p>\n

Okta (OKTA) \u2014 Bank of America raised its price target for the stock to $200.00 from $170.00 while maintaining a Neutral rating.<\/p>\n

Okta (OKTA) \u2014 Barclays raised its price target for the stock to $215.00 from $180.00 while maintaining a Overweight rating.<\/p>\n

Okta (OKTA) \u2014 BTIG Research reiterated its Buy rating on the stock with a price target of $219.00.<\/p>\n

Okta (OKTA) \u2014 Citigroup reiterated its Neutral rating on the stock.<\/p>\n

Okta (OKTA) \u2014 DA Davidson raised its price target for the stock to $235.00 from $190.00 while maintaining a Buy rating.<\/p>\n

Okta (OKTA) \u2014 Evercore reiterated its Outperform rating on the stock with a price target of $240.00.<\/p>\n

Okta (OKTA) \u2014 Guggenheim raised its price target for the stock to $227.00 from $188.00 while maintaining a Buy rating.<\/p>\n

Okta (OKTA) \u2014 Jefferies Financial Group raised its price target for the stock to $240.00 from $200.00 while maintaining a Buy rating.<\/p>\n

Okta (OKTA) \u2014 KeyCorp set a price target of $240.00 for the stock with an Overweight rating.<\/p>\n

Okta (OKTA) \u2014 Mizuho raised its price target for the stock to $200.00 from $165.00 while maintaining a Neutral rating.<\/p>\n

Okta (OKTA) \u2014 New Street Research set a price target of $235.00 for the stock.<\/p>\n

Okta (OKTA) \u2014 Oppenheimer raised its price target for the stock to $227.00 from $190.00 while maintaining a Outperform rating.<\/p>\n

Okta (OKTA) \u2014 Roth Capital raised its price target for the stock to $235.00 from $155.00 while maintaining a Buy rating.<\/p>\n

Okta (OKTA) \u2014 Royal Bank Of Canada raised its price target for the stock to $230.00 from $195.00 while maintaining a Outperform rating.<\/p>\n

Okta (OKTA) \u2014 Stifel Nicolaus raised its price target for the stock to $215.00 from $180.00 while maintaining a Buy rating.<\/p>\n

Okta (OKTA) \u2014 TD Cowen raised its price target for the stock to $200.00 from $175.00 while maintaining a Hold rating.<\/p>\n

Okta (OKTA) \u2014 Truist Financial set a price target of $235.00 for the stock.<\/p>\n

Okta (OKTA) \u2014 Wells Fargo & Company raised its price target for the stock to $230.00 from $200.00 while maintaining a Overweight rating.<\/p>\n

Old National Bancorp (ONB) \u2014 Wells Fargo initiated coverage of the company with an Overweight rating and a price target of $30.<\/p>\n

ON (ONON) \u2014 Barclays raised its price target for the stock to $44.00 from $42.00 while maintaining a Overweight rating.<\/p>\n

ON (ONON) \u2014 BMO Capital Markets raised its price target for the stock to $33.00 from $28.00 while maintaining a Market Perform rating.<\/p>\n

ON (ONON) \u2014 Piper Sandler reiterated its Overweight rating on the stock with a price target of $45.00.<\/p>\n

ON (ONON) \u2014 Sanford C. Bernstein reiterated its Outperform rating on the stock.<\/p>\n

Oruka Therapeutics (ORKA) \u2014 HC Wainwright reiterated its Buy rating on the stock with a price target of $120.00.<\/p>\n

Oruka Therapeutics (ORKA) \u2014 Wedbush reiterated its Outperform rating on the stock with a price target of $165.00.<\/p>\n

Otis Worldwide (OTIS) \u2014 Wells Fargo & Company initiated coverage of the company with an Underweight rating and a price target of $77.00.<\/p>\n

Parker-Hannifin (PH) \u2014 Wells Fargo & Company set a price target of $1,050.00 for the stock.<\/p>\n

Paychex (PAYX) \u2014 BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $113 from $118.<\/p>\n

Paychex (PAYX) \u2014 Jefferies Financial Group lowered its price target for the stock to $110.00 from $120.00 while maintaining a Hold rating.<\/p>\n

Paychex (PAYX) \u2014 JP Morgan upgraded the stock from Underweight to Neutral and raised its price target to $115.00 from $105.00.<\/p>\n

Paychex (PAYX) \u2014 Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $130.00.<\/p>\n

Paychex (PAYX) \u2014 Stephens lowered its price target for the stock to $113.00 from $132.00 while maintaining a Equal Weight rating.<\/p>\n

Paychex (PAYX) \u2014 Stifel Nicolaus lowered its price target for the stock to $112.00 from $130.00 while maintaining a Hold rating.<\/p>\n

Paychex (PAYX) \u2014 UBS Group lowered its price target for the stock to $115.00 from $125.00 while maintaining a Neutral rating.<\/p>\n

PepsiCo (PEP) \u2014 Citigroup reiterated its Neutral rating on the stock and lowered its price target to $142 from $145.<\/p>\n

Permian Resources (PR) \u2014 Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $27.00.<\/p>\n

Phillips Edison & Company, Inc. (PECO) \u2014 Mizuho lowered its price target for the stock to $39.00 from $43.00 while maintaining a Outperform rating.<\/p>\n

Phillips Edison & Company, Inc. (PECO) \u2014 UBS Group set a price target of $39.00 for the stock.<\/p>\n

Portland General Electric (POR) \u2014 KeyCorp reiterated its Sector Weight rating on the stock.<\/p>\n

PPG Industries (PPG) \u2014 Sanford C. Bernstein reiterated its Outperform rating on the stock with a price target of $136.00.<\/p>\n

Praxis Precision Medicines (PRAX) \u2014 HC Wainwright reiterated its Buy rating on the stock with a price target of $1,201.00.<\/p>\n

Praxis Precision Medicines (PRAX) \u2014 Needham & Company LLC reiterated its Buy rating on the stock with a price target of $582.00.<\/p>\n

PubMatic (PUBM) \u2014 Craig Hallum initiated coverage of the company with a Buy rating and a price target of $24.<\/p>\n

Quanta Services (PWR) \u2014 Bernstein upgraded the stock from Market Perform to Outperform and set a price target of $775.<\/p>\n

Quanta Services (PWR) \u2014 Sanford C. Bernstein upgraded the stock from Market Perform to Outperform and raised its price target to $775.00 from $748.00.<\/p>\n

Quince Therapeutics (QNCX) \u2014 Rodman & Renshaw initiated coverage of the company with a Buy rating and a price target of $70.<\/p>\n

Regency Centers (REG) \u2014 JPMorgan Chase & Co. upgraded the stock from Neutral to Overweight and set a price target of $83.00.<\/p>\n

Regency Centers (REG) \u2014 Mizuho lowered its price target for the stock to $76.00 from $82.00 while maintaining a Neutral rating.<\/p>\n

Regency Centers (REG) \u2014 The Goldman Sachs Group set a price target of $83.00 for the stock.<\/p>\n

Revolution Medicines (RVMD) \u2014 Goldman resumed coverage of the company with a Buy rating and a price target of $267.<\/p>\n

Rockwell Automation (ROK) \u2014 Wells Fargo & Company set a price target of $426.00 for the stock.<\/p>\n

Roivant Sciences (ROIV) \u2014 Cantor Fitzgerald reiterated its Overweight rating on the stock.<\/p>\n

Roku (ROKU) \u2014 Wedbush reiterated its Neutral rating on the stock with a price target of $155.00.<\/p>\n

Rollins (ROL) \u2014 Piper Sandler downgraded the stock from Overweight to Neutral and set a price target of $33.<\/p>\n

Royal Caribbean Cruises (RCL) \u2014 JPMorgan Chase & Co. raised its price target for the stock to $394.00 from $345.00 while maintaining a Overweight rating.<\/p>\n

Royal Caribbean Cruises (RCL) \u2014 Truist Financial raised its price target for the stock to $298.00 from $297.00 while maintaining a Hold rating.<\/p>\n

Safehold (SAFE) \u2014 JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $14.<\/p>\n

Sagimet Biosciences (SGMT) \u2014 Goldman resumed coverage of the company with a Sell rating and a price target of $7.<\/p>\n

SailPoint (SAIL) \u2014 Truist Financial raised its price target for the stock to $27.00 from $23.00 while maintaining a Buy rating.<\/p>\n

Scholar Rock (SRRK) \u2014 Truist Financial raised its price target for the stock to $77.00 from $76.00 while maintaining a Buy rating.<\/p>\n

Sherwin-Williams (SHW) \u2014 Mizuho set a price target of $396.00 for the stock.<\/p>\n

Shift4 Payments (FOUR) \u2014 Mizuho lowered its price target for the stock to $46.00 from $55.00 while maintaining a Outperform rating.<\/p>\n

Shopify (SHOP) \u2014 Mizuho set a price target of $180.00 for the stock.<\/p>\n

Solaris Energy Infrastructure (SEI) \u2014 Citigroup raised its price target for the stock to $100.00 from $84.00 while maintaining a Buy rating.<\/p>\n

Solaris Energy Infrastructure (SEI) \u2014 Stifel Nicolaus raised its price target for the stock to $101.00 from $98.00 while maintaining a Buy rating.<\/p>\n

Southwest Airlines (LUV) \u2014 UBS Group raised its price target for the stock to $53.00 from $49.00 while maintaining a Buy rating.<\/p>\n

Spruce Biosciences (SPRB) \u2014 Citizens Jmp reiterated its Market Outperform rating on the stock with a price target of $144.00.<\/p>\n

StandardAero (SARO) \u2014 Jefferies Financial Group set a price target of $25.00 for the stock.<\/p>\n

Starwood Property Trust (STWD) \u2014 Citigroup reiterated its Market Outperform rating on the stock.<\/p>\n

Stitch Fix (SFIX) \u2014 Northland Securities set a price target of $4.00 for the stock.<\/p>\n

Stitch Fix (SFIX) \u2014 Sanford C. Bernstein reiterated its Market Perform rating on the stock with a price target of $4.00.<\/p>\n

Stitch Fix (SFIX) \u2014 Telsey Advisory Group reiterated its Market Perform rating on the stock and lowered its price target to $3 from $5.<\/p>\n

Stitch Fix (SFIX) \u2014 UBS Group lowered its price target for the stock to $3.50 from $4.00 while maintaining a Neutral rating.<\/p>\n

Stitch Fix (SFIX) \u2014 William Blair downgraded the stock from Outperform to Market Perform.<\/p>\n

Synopsys (SNPS) \u2014 BNP Paribas Exane upgraded the stock from Underperform to Neutral and set a price target of $420.<\/p>\n

Tandem Diabetes Care (TNDM) \u2014 Truist Financial lowered its price target for the stock to $28.00 from $31.00 while maintaining a Buy rating.<\/p>\n

Tanger Factory (SKT) \u2014 JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $39.<\/p>\n

Tarsus Pharmaceuticals (TARS) \u2014 Goldman resumed coverage of the company with a Buy rating and a price target of $116.<\/p>\n

Tesla (TSLA) \u2014 BNP Paribas Exane lowered its price target for the stock to $268.00 from $280.00 while maintaining a Underperform rating.<\/p>\n

Tesla (TSLA) \u2014 UBS Group reiterated its Neutral rating on the stock.<\/p>\n

Theravance Biopharma (TBPH) \u2014 BTIG Research reiterated its Neutral rating on the stock.<\/p>\n

TransUnion (TRU) \u2014 UBS Group lowered its price target for the stock to $80.00 from $82.00 while maintaining a Neutral rating.<\/p>\n

Travere Therapeutics (TVTX) \u2014 Guggenheim raised its price target for the stock to $89.00 from $75.00 while maintaining a Buy rating.<\/p>\n

Twilio (TWLO) \u2014 HSBC downgraded the stock from Hold to Reduce and set a price target of $211.00.<\/p>\n

Tyler Technologies (TYL) \u2014 BTIG Research reiterated its Buy rating on the stock with a price target of $400.00.<\/p>\n

UiPath (PATH) \u2014 BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $15 from $18.<\/p>\n

UiPath (PATH) \u2014 Canaccord Genuity Group lowered its price target for the stock to $14.00 from $17.00 while maintaining a Hold rating.<\/p>\n

UiPath (PATH) \u2014 KeyCorp reiterated its Sector Weight rating on the stock.<\/p>\n

UiPath (PATH) \u2014 New Street Research set a price target of $15.00 for the stock.<\/p>\n

UL Solutions (ULS) \u2014 Robert W. Baird lowered its price target for the stock to $85.00 from $95.00 while maintaining a Outperform rating.<\/p>\n

Union Pacific (UNP) \u2014 Royal Bank Of Canada set a price target of $326.00 for the stock.<\/p>\n

United Airlines (UAL) \u2014 UBS Group raised its price target for the stock to $146.00 from $137.00 while maintaining a Buy rating.<\/p>\n

United Rentals (URI) \u2014 Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $1,323.00.<\/p>\n

United Therapeutics (UTHR) \u2014 Goldman initiated coverage of the company with a Sell rating and a price target of $321.<\/p>\n

Vail Resorts (MTN) \u2014 Mizuho lowered its price target for the stock to $160.00 from $174.00 while maintaining a Outperform rating.<\/p>\n

Vail Resorts (MTN) \u2014 Stifel Nicolaus lowered its price target for the stock to $161.00 from $167.00 while maintaining a Buy rating.<\/p>\n

Versant (VSNT) \u2014 Citigroup initiated coverage of the company with a Buy rating and a price target of $41.<\/p>\n

Vertiv (VRT) \u2014 Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $340.00.<\/p>\n

VICI Properties (VICI) \u2014 JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $30.<\/p>\n

VICI Properties (VICI) \u2014 Scotiabank lowered its price target for the stock to $26.00 from $29.00 while maintaining a Sector Perform rating.<\/p>\n

Viking (VIK) \u2014 Truist Financial lowered its price target for the stock to $98.00 from $102.00 while maintaining a Buy rating.<\/p>\n

W.P. Carey (WPC) \u2014 Scotiabank lowered its price target for the stock to $68.00 from $76.00 while maintaining a Sector Perform rating.<\/p>\n

Welltower (WELL) \u2014 JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $260.<\/p>\n

Western Union (WU) \u2014 Citigroup reiterated its Neutral rating on the stock.<\/p>\n

WEX (WEX) \u2014 Deutsche Bank Aktiengesellschaft reiterated its Hold rating on the stock.<\/p>\n

Wintrust Fin (WTFC) \u2014 Wells Fargo initiated coverage of the company with an Equal Weight rating and a price target of $160.<\/p>\n

Worthington Enterprises (WOR) \u2014 Canaccord Genuity Group raised its price target for the stock to $75.00 from $67.00 while maintaining a Buy rating.<\/p>\n

Yum! Brands (YUM) \u2014 Argus downgraded the stock from Buy to Hold.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings: The latest 340 Canadian and US analyst updates suggest a selective market outlook. Target cuts across asset management, gold mining, real estate,…<\/p>\n","protected":false},"author":3,"featured_media":75299,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-75295","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nAnalyst Updates: Sept 24, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analyst Updates: Sept 24, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings: The latest 340 Canadian and US analyst updates suggest a selective market outlook. Target cuts across asset management, gold mining, real estate,…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-25T05:30:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/09\/ChatGPT-Image-Sep-25-2026-01_23_26-AM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"28 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Analyst Updates: Sept 24, 2026\",\"datePublished\":\"2026-09-25T05:30:30+00:00\",\"dateModified\":\"2026-09-25T05:30:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/\"},\"wordCount\":5978,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/\",\"name\":\"Analyst Updates: Sept 24, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-09-25T05:30:30+00:00\",\"dateModified\":\"2026-09-25T05:30:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analyst Updates: Sept 24, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Analyst Updates: Sept 24, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/","og_locale":"en_US","og_type":"article","og_title":"Analyst Updates: Sept 24, 2026","og_description":"Analyst Ratings: The latest 340 Canadian and US analyst updates suggest a selective market outlook. Target cuts across asset management, gold mining, real estate,…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-09-25T05:30:30+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/09\/ChatGPT-Image-Sep-25-2026-01_23_26-AM.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"28 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Analyst Updates: Sept 24, 2026","datePublished":"2026-09-25T05:30:30+00:00","dateModified":"2026-09-25T05:30:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/"},"wordCount":5978,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/","name":"Analyst Updates: Sept 24, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-09-25T05:30:30+00:00","dateModified":"2026-09-25T05:30:30+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-updates-sept-24-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Analyst Updates: Sept 24, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=75295"}],"version-history":[{"count":8,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75295\/revisions"}],"predecessor-version":[{"id":75307,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75295\/revisions\/75307"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/75299"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=75295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=75295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=75295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}